Invesco Ltd. Grows Stock Position in Integral Ad Science Holding Corp. $IAS

Key Points

• Invesco Ltd. increased its stake in Integral Ad Science by 97.7% to 99,932 shares, worth approximately $805,000, as reported in its recent SEC filing.
• Several other hedge funds, including UBS Asset Management and Envestnet Asset Management, also significantly increased their holdings in Integral Ad Science, reflecting a strong interest from institutional investors.
• Integral Ad Science reported earnings of $0.07 EPS for the latest quarter, surpassing expectations with revenue of $149.20 million, outperforming analyst estimates of $143.02 million.

Invesco Ltd. lifted its stake in Integral Ad Science Holding Corp. (NASDAQ:IAS - Free Report) by 97.7% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 99,932 shares of the company's stock after acquiring an additional 49,388 shares during the period. Invesco Ltd. owned approximately 0.06% of Integral Ad Science worth $805,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in the stock. Vanguard Group Inc. boosted its holdings in shares of Integral Ad Science by 0.5% in the first quarter. Vanguard Group Inc. now owns 9,090,229 shares of the company's stock worth $73,267,000 after acquiring an additional 41,683 shares during the period. Nuveen Asset Management LLC boosted its holdings in shares of Integral Ad Science by 0.8% in the fourth quarter. Nuveen Asset Management LLC now owns 1,920,523 shares of the company's stock worth $20,050,000 after acquiring an additional 15,432 shares during the period. Invenomic Capital Management LP boosted its holdings in shares of Integral Ad Science by 52.9% in the fourth quarter. Invenomic Capital Management LP now owns 895,061 shares of the company's stock worth $9,344,000 after acquiring an additional 309,752 shares during the period. Northern Trust Corp boosted its holdings in shares of Integral Ad Science by 11.0% in the fourth quarter. Northern Trust Corp now owns 677,204 shares of the company's stock worth $7,070,000 after acquiring an additional 67,038 shares during the period. Finally, Clearline Capital LP bought a new position in shares of Integral Ad Science in the fourth quarter worth $3,949,000. 95.78% of the stock is owned by institutional investors.

Analysts Set New Price Targets

IAS has been the subject of a number of analyst reports. Stifel Nicolaus raised their price target on Integral Ad Science from $13.00 to $14.00 and gave the stock a "buy" rating in a report on Tuesday, July 22nd. Raymond James Financial dropped their price objective on Integral Ad Science from $13.00 to $11.00 and set an "outperform" rating for the company in a research note on Friday, August 8th. Barclays lifted their price objective on Integral Ad Science from $9.00 to $10.00 and gave the company an "equal weight" rating in a research note on Friday, August 8th. Finally, Wall Street Zen raised Integral Ad Science from a "hold" rating to a "buy" rating in a research note on Sunday, August 10th. Six analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company's stock. According to MarketBeat.com, Integral Ad Science presently has an average rating of "Moderate Buy" and an average price target of $13.55.

Integral Ad Science Price Performance

IAS stock traded down $0.26 during mid-day trading on Tuesday, hitting $8.55. 765,308 shares of the stock were exchanged, compared to its average volume of 787,678. The business has a fifty day moving average price of $8.56 and a 200 day moving average price of $8.28. Integral Ad Science Holding Corp. has a 12 month low of $6.26 and a 12 month high of $13.62. The stock has a market capitalization of $1.42 billion, a price-to-earnings ratio of 25.15, a PEG ratio of 1.25 and a beta of 1.57.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.04 by $0.03. Integral Ad Science had a return on equity of 5.00% and a net margin of 9.79%.The firm had revenue of $149.20 million during the quarter, compared to analyst estimates of $143.02 million. Integral Ad Science has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. As a group, equities analysts forecast that Integral Ad Science Holding Corp. will post 0.26 EPS for the current fiscal year.

Insider Transactions at Integral Ad Science

In other Integral Ad Science news, CEO Lisa Utzschneider sold 9,922 shares of Integral Ad Science stock in a transaction dated Wednesday, August 6th. The stock was sold at an average price of $8.12, for a total transaction of $80,566.64. Following the completion of the sale, the chief executive officer owned 380,557 shares of the company's stock, valued at $3,090,122.84. The trade was a 2.54% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders sold a total of 35,073 shares of company stock worth $289,641 over the last three months. Insiders own 2.00% of the company's stock.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.